These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 30693648

  • 21. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
    Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, Prignano F.
    Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
    [Abstract] [Full Text] [Related]

  • 22. Diagnosis and management of hidradenitis suppurativa in women.
    Collier EK, Parvataneni RK, Lowes MA, Naik HB, Okun M, Shi VY, Hsiao JL.
    Am J Obstet Gynecol; 2021 Jan; 224(1):54-61. PubMed ID: 32980357
    [Abstract] [Full Text] [Related]

  • 23. Local wound care and topical management of hidradenitis suppurativa.
    Alavi A, Kirsner RS.
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S55-61. PubMed ID: 26470618
    [Abstract] [Full Text] [Related]

  • 24. Color Doppler as a tool for correlating vascularization and pain in hidradenitis suppurativa lesions.
    Nazzaro G, Passoni E, Calzari P, Barbareschi M, Muratori S, Veraldi S, Marzano AV.
    Skin Res Technol; 2019 Nov; 25(6):830-834. PubMed ID: 31140660
    [Abstract] [Full Text] [Related]

  • 25. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ, Karaçin C, Adışen E, Güz G, Ali Gürer M.
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [Abstract] [Full Text] [Related]

  • 26. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
    Boer J, Jemec GB.
    Clin Exp Dermatol; 2010 Jan; 35(1):36-40. PubMed ID: 19549239
    [Abstract] [Full Text] [Related]

  • 27. A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs.
    Holcomb ZE, Porter ML, Kimball AB.
    Expert Opin Drug Saf; 2021 Oct; 20(10):1147-1161. PubMed ID: 33910441
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hidradenitis Suppurativa: Rapid Evidence Review.
    Wipperman J, Bragg DA, Litzner B.
    Am Fam Physician; 2019 Nov 01; 100(9):562-569. PubMed ID: 31674740
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide-10 in the adjuvant treatment of hidradenitis suppurativa: Real-life data.
    Skroza N, Mambrin A, Tolino E, Marchesiello A, Proietti I, Bernardini N, Potenza C.
    Dermatol Ther; 2018 Jul 01; 31(4):e12599. PubMed ID: 29642279
    [Abstract] [Full Text] [Related]

  • 31. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
    Hunger RE, Laffitte E, Läuchli S, Mainetti C, Mühlstädt M, Schiller P, Lapointe AK, Meschberger P, Navarini AA.
    Dermatology; 2017 Jul 01; 233(2-3):113-119. PubMed ID: 28683447
    [Abstract] [Full Text] [Related]

  • 32. Complications of hidradenitis suppurativa.
    Yuan JT, Naik HB.
    Semin Cutan Med Surg; 2017 Jun 01; 36(2):79-85. PubMed ID: 28538749
    [Abstract] [Full Text] [Related]

  • 33. Hidradenitis suppurativa: a review of current treatment options.
    Lewandowski M, Świerczewska Z, Barańska-Rybak W.
    Int J Dermatol; 2022 Sep 01; 61(9):1152-1164. PubMed ID: 35128643
    [Abstract] [Full Text] [Related]

  • 34. [Gynecological aspects of hidradenitis suppurativa].
    Kiss N, Plázár D, Lőrincz K, Bánvölgyi A, Valent S, Wikonkál N.
    Orv Hetil; 2019 Feb 01; 160(8):291-299. PubMed ID: 30773037
    [Abstract] [Full Text] [Related]

  • 35. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].
    Patel ZS, Hoffman LK, Buse DC, Grinberg AS, Afifi L, Cohen SR, Lowes MA, Seng EK.
    Curr Pain Headache Rep; 2017 Nov 01; 21(12):49. PubMed ID: 29094219
    [Abstract] [Full Text] [Related]

  • 36. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
    Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB.
    Ann Intern Med; 2012 Dec 18; 157(12):846-55. PubMed ID: 23247938
    [Abstract] [Full Text] [Related]

  • 37. Steatocystoma multiplex suppurativa associated with hidradenitis suppurativa successfully treated with adalimumab.
    Atzori L, Zanniello R, Pilloni L, Rongioletti F.
    J Eur Acad Dermatol Venereol; 2019 Oct 18; 33 Suppl 6():42-44. PubMed ID: 31535759
    [Abstract] [Full Text] [Related]

  • 38. [Treatment options in severe hidradenitis suppurativa].
    Mooij JE, van't Oost L, Leenarts MF, Mekkes JR.
    Ned Tijdschr Geneeskd; 2011 Oct 18; 155():A1912. PubMed ID: 21426594
    [Abstract] [Full Text] [Related]

  • 39. Botulinum toxin type A for the management of hidradenitis suppurativa.
    Qu H, Gao L.
    Am J Transl Res; 2021 Oct 18; 13(12):14115-14120. PubMed ID: 35035756
    [Abstract] [Full Text] [Related]

  • 40. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
    Leslie KS, Tripathi SV, Nguyen TV, Pauli M, Rosenblum MD.
    J Am Acad Dermatol; 2014 Feb 18; 70(2):243-51. PubMed ID: 24314876
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.